Oocyte (1st polar body) |
Removal has no effect on embryo development Increased time to perform PCR analysis prior to transfer |
Only 1 cell available for analysis Increased risk of diagnostic error Maternally inherited disease only Fewer embryos for transfer (recombination) |
Zygote (1st and 2nd polar body) |
2 cells for analysis (greater accuracy/reliability) Removal has no effect on embryo development Increased time to perform PCR analysis prior to transfer |
Maternally inherited disease only Narrow time window to complete biopsy |
Cleavage stage (blastomeres) |
Diagnosis of maternally/paternally inherited disorders Large body of clinical data available 2 cells available for analysis (greater accuracy/reliability) |
Chromosomal mosaicism present Selection of nucleated blastomere is critical |
Blastocyst (trophectoderm) |
Sample multiple cells (eliminate PCR failure/ADO) Trophectoderm sampled rather than inner cell mass Embryo quality preselected Higher implantation rate/lower multiple gestation rate |
Time for PCR analysis may be limited Cells may not be representative of embryo Fewer embryos for analysis Limited clinical data available |